University of Connecticut

Gastroenterology Abstracts On The Go

Health EN ↓ 51 episodes

A monthly deep dive into the most influential and practice-shaping publications in Gastroenterology. Each episode breaks down key studies, highlights clinical implications, and offers clear, evidence-based insights for busy clinicians, trainees, and researchers. Whether it’s landmark trials, emerging therapies, or updated guidelines, this podcast brings the latest GI literature to life—helping listeners stay current, think critically, and apply new knowledge at the bedside.

Author

University of Connecticut

Category

Health

Podcast website

redcircle.com

Latest episode

Mar 24, 2026

Where to listen?

Podcasts in the app Replaio Radio Coming soon

Podcasts are coming to the app soon. Install now and be the first to see a whole new take on podcasts

Get it on Google Play Install for free Android 5M+ downloads · 4.8 rating iOS soon

Episodes

Gastroenterology April 2026 Prognostic Performance of Phosphatidylethanol With Noninvasive Liver Fibrosis Tests in Alcohol-Related Liver Disease 24.03.2026

This study evaluates how effectively a specific blood biomarker, phosphatidylethanol (PEth), can forecast severe liver complications in individuals at risk for alcohol-related liver disease. While traditional noninvasive tests primarily measure existing liver scarring or fibrosis, this research demonstrates that tracking PEth levels provides a distinct, independent layer of prognostic data regardi...

Gastroenterology April 2026 Genetic Risk of Inflammatory Bowel Disease Is Associated With Disease Course Severity 24.03.2026

This study investigates whether a person’s inherited predisposition to inflammatory bowel disease (IBD) also determines how aggressively the condition will progress. By analyzing thousands of patients, researchers found that individuals with a higher genetic burden faced significantly more hospitalizations, surgeries, and a greater need for intensive drug therapies. While the severity of Crohn’s d...

Gastroenterology April 2026 Faecalibacterium prausnitzii Induces an Anti-inflammatory Response and a Metabolic Reprogramming in Human Monocytes 24.03.2026

This study explores how a common gut bacterium, Faecalibacterium prausnitzii, protects human health by directly influencing immune cells to reduce inflammation. Researchers discovered that this specific microbe triggers a dose-dependent production of IL10, a vital anti-inflammatory signal, within monocytes located in both the blood and the intestines. Unlike other bacteria, F. prausnitzii achieves...

Gastro Hep Advances March 2026 Iron Deficiency Anemia Is Associated With Gastric Intestinal Metaplasia in Patients With Helicobacter pylori Infection 05.03.2026

This study investigates the medical correlation between iron deficiency anemia and the development of gastric intestinal metaplasia, a condition considered a precursor to stomach cancer. By examining a cohort of patients infected with H. pylori, researchers discovered that those suffering from low iron were significantly more likely to exhibit these precancerous lesions. The risk was particularly...

Gastroenterology March 2026 Mutational Landscape of Colorectal Tumors From Individuals With Unexplained Adenomatous or Serrated Colorectal Polyposis 27.02.2026

This research investigates the genetic origins of colorectal polyps in patients who lack a known hereditary diagnosis for their condition. By analyzing the somatic mutations and molecular signatures of nearly 300 tumors, the study highlights how specific genetic drivers like APC and BRAF distinguish different types of growths. A key discovery is that serrated polyps appear molecularly closer to he...

Gastroenterology February 2026 Gastric Organoid-Based Ectopic and Orthotopic In Vivo CRISPR Screening for Tumor Suppressors in Gastric Cancer 27.02.2026

This research utilizes CRISPR-Cas9 gene-editing technology to identify specific genes that normally prevent the development of stomach cancer. By testing thousands of potential targets within mouse-derived organoids, the researchers discovered that the loss of genes like Pten and those in the TGF-ß pathway significantly accelerates tumor growth and creates early-stage cancer lesions. The study fur...

Gastroenterology February 2026 AGA Clinical Practice Update on Inpatient Management of Adults With Inflammatory Bowel Disease: Expert Review Description 27.02.2026

The American Gastroenterological Association developed these guidelines to standardize the complex care required for adults hospitalized with severe inflammatory bowel disease. By addressing thirteen critical clinical areas, the text provides a framework for prompt evaluation, ranging from the use of biomarkers and endoscopy to the proactive prevention of venous thromboembolism. The recommendation...

Lancet February 2026 Best buys for metabolic dysfunction-associated steatotic liver disease and metabolic dysfunction-associated steatohepatitis: a global Delphi study 25.02.2026

This study highlights a critical gap in global health policy, as liver diseases like MASLD and MASH are currently missing from the World Health Organization’s primary strategies for non-communicable diseases. By surveying hundreds of international experts, the research establishes a strong global consensus on fifteen essential interventions that should be prioritized for their high impact and feas...

Lancet February 2026 Cyclic exclusive enteral nutrition versus partial enteral nutrition to maintain long-term drug-free remission in paediatric Crohn's disease (CD-HOPE): an open-label, endpoint-blinded, randomised controlled trial 25.02.2026

This research study investigated whether specialized liquid diets could successfully maintain long-term clinical remission in children with Crohn's disease without the need for traditional pharmaceutical drugs. Researchers compared two distinct methods: a cyclic approach involving two-week bursts of an exclusive liquid diet every two months, and a partial approachwhere patients consumed a smal...

Lancet February 2026 Appendicectomy versus switching to a JAK inhibitor in inducing remission in patients with active ulcerative colitis after biologic therapy failure (COSTA): 1-year results of a multicentre, prospective, cohort study 25.02.2026

This study investigated whether surgical removal of the appendix could help patients with severe ulcerative colitis who no longer respond to standard biological medications. By comparing this procedure to the alternative of switching to JAK inhibitor drugs, researchers found that patients who underwent an appendicectomy were significantly more likely to achieve long-term clinical remission. Beyond...

JAMA February 2026 Prevalence of Colorectal Cancer Screening Among Latino Adults Following the Medicaid Eligibility Amendment Expansion 12.02.2026

This research study investigates whether broadening Medicaid eligibilityto include low-income adults regardless of their immigration status helps improve preventative healthcare outcomes. By comparing patients in states that adopted these inclusive policies against those that did not, the authors found a significant increase in colorectal cancer screenings among various Latino and Latina subgroups...

BMJ Gut February 2026:Galectin-4 drives anti-PD-L1/BVZ resistance by regulating metabolic adaptation and tumour-associated neutrophils in hepatocellular carcinoma 10.02.2026

This research investigates why most liver cancer patients fail to respond to standard combined immunotherapy, identifying a protein called galectin-4as a primary culprit behind treatment resistance. By stabilizing metabolic enzymes and triggering specific chemical signals, galectin-4 forces the tumor into a state of metabolic adaptation that effectively shields it from the immune system. This proc...

BMJ GUT February 2026:Towards optimising and standardising donor screening for faecal microbiota transplantion. 10.02.2026

To address the lack of uniform evidence-based standards, this article proposes a rationalized framework for screening stool donors to ensure the safety of fecal microbiota transplants. The authors conducted a comparative review of existing guidelines and utilized an expert Delphi process to balance the prevention of pathogen transmission with the need to maintain an adequate donor supply. By advoc...

Lancet Gastroenterology Efficacy and safety of mirikizumab in paediatric participants with moderately-to-severely active ulcerative colitis (SHINE-1): a multicentre, open-label, non-randomised phase 2 trial.Background 05.02.2026

The SHINE-1 study explored the potential of mirikizumab, a specialized antibody treatment, for children and adolescents suffering from moderate-to-severe ulcerative colitis who had failed previous therapies. By blocking a specific inflammatory protein known as IL-23, the drug aimed to reduce intestinal damage and provide long-term relief through a sequence of intravenous and subcutaneous doses. Th...

JAMA Gastroenterology January 2026:Antibiotic Therapy for Uncomplicated Acute Appendicitis: Ten-Year Follow-Up of the APPAC Randomized Clinical Trial 28.01.2026

This long-term clinical study evaluates whether treating uncomplicated appendicitis with medication is a viable alternative to traditional surgery over a ten-year period. By tracking hundreds of patients, researchers found that while nearly 40% of those who took antibiotics eventually experienced a recurrence, the majority avoided surgery entirely without sacrificing their overall quality of life....

Gastroenterology February 2026: The Prevalence and Burden of Avoidant/Restrictive Food Intake Disorder Symptoms in Adults With Disorders of Gut-Brain Interaction: A Population-Based Study 28.01.2026

This population-based study investigates the strong correlation between disorders of gut-brain interaction (DGBI) and avoidant/restrictive food intake disorder (ARFID) among the general adult population in the United Kingdom and United States. The researchers discovered that individuals suffering from digestive issues are significantly more likely to restrict their food intake, with the risk of di...

Gastroenterology February 2026:The Disease Burden of Helicobacter pylori Beyond Gastric Cancer 28.01.2026

While health policies often focus on the link between Helicobacter pylori and stomach cancer, this research highlights the massive global burden of other conditions caused by the bacteria, such as peptic ulcers and indigestion. By analyzing international data, the authors demonstrate that eradicating the infection could prevent millions of cases of illness, suggesting that current medical guidelin...

Clinical Gastroenterology and Hepatology; January 2026 Long-Term Mortality After Cholecystectomy in a Nationwide Cohort of Swedish Individuals Between 1969 and 2016 18.01.2026

This nationwide Swedish study investigated the long-term survival rates of nearly 160,000 patients who underwent gallbladder removal surgery over several decades. By comparing these patients to the general public, researchers discovered a distinct age-based disparity in mortality outcomes following the procedure. While older patients generally experienced lower mortality, those who had the surgery...

Clinical Gastroenterology and Hepatology; January 2026 Comparative Effectiveness of Empiric Treatment for Helicobacter pylori in a Large, Diverse Population in the United States 18.01.2026

This comprehensive study evaluates the success rates of various antibiotic combinations used to eliminate H. pylori infections within a diverse American population. The research highlights that four-drug regimens, specifically concomitant and bismuth-based quadruple therapies, serve as the most effective initial treatments and maintain their potency over time. Crucially, the data suggests that pri...

Clinical Gastroenterology and Hepatology; January 2026 Diagnosis of Retrograde Cricopharyngeus Dysfunction Using High Resolution Impedance Manometry and Comparison With Control Subjects 18.01.2026

This research investigates Retrograde Cricopharyngeus Dysfunction (R-CPD), a condition where the throat muscle fails to relax, making it impossible for a person to belch. By using advanced pressure-sensing technology during a sparkling water provocation test, scientists discovered that patients with this disorder maintain excessively high pressure in the upper esophageal sphincter, causing gas to...

World J Gastroenterol . 2025 Aug Positioning and sequencing of advanced therapies in inflammatory bowel disease: A guide for clinical practice 15.01.2026

This academic review explores the modern landscape of inflammatory bowel disease treatment, which has evolved from a limited selection of drugs to a diverse array of advanced biological and molecular therapies. As the number of available medications increases, clinicians face the growing challenge of optimizing the sequence and positioning of these treatments to manage complex patient cases effect...

World J Gastroenterol . 2025 Jun 14 Exploring the gut-exercise link: A systematic review of gastrointestinal disorders in physical activity 15.01.2026

This systematic review investigates the bidirectional relationship between physical activity and digestive well-being, highlighting how exercise can serve as both a remedy and a stressor for the gut. By synthesizing hundreds of studies, the authors demonstrate that moderate movement enhances intestinal motility and reduces inflammation, offering significant relief for chronic conditions like irrit...

World J Gastroenterol . 2025 May 28 Metabolic dysfunction-associated steatotic liver disease: A story of muscle and mass 15.01.2026

This text explores the intricate bidirectional relationship between metabolic liver disease and skeletal muscle health, illustrating how physical decline both mirrors and worsens hepatic damage. The author identifies sarcopenia and myosteatosis—the loss of muscle mass and the infiltration of fat into muscle tissue—as critical factors that drive insulin resistance and systemic inflammation, ultimat...

Gastroenterology January 2026 Enhancement of Inpatient Mortality Prognostication With Machine Learning in a Prospective Global Cohort of Patients With Cirrhosis With External Validation 13.01.2026

In a prospectively recruited cohort of 7239 patients hospitalized with cirrhosis (Chronic Liver Disease Evolution and Registry for Events and Decompensation [CLEARED]) from 115 centers across all 6 populated continents, it was determined that a random forest machine learning model significantly enhanced inpatient mortality prediction over other models and traditional logistic regression. This rand...

Gastroenterology January 2026 The Natural History of Gastroesophageal Varices in Children With Portal Hypertension 12.01.2026

This long-term study tracks how gastroesophageal varices evolve in children suffering from high blood pressure in the portal vein. The researchers discovered that internal conditions frequently deteriorate over time, with more than half of the subjects developing high-risk lesionswithin a decade of their first checkup. Young patients with biliary atresiawere identified as being at an especially hi...

Listen to the Gastroenterology Abstracts On The Go podcast in Replaio

Radio and podcasts in one app - free, with no sign-up. Install today and do not miss the launch

Get it on Google Play

Replaio is not a podcast publisher; show names, artwork and audio belong to their authors and are distributed through public RSS feeds.